Handelsavisen
prelaunch
Companies Healthcare DSOL.PK
DS
DSOL.PK OTC Healthcare Facilities & Services

Drug Free Solution Inc

$0,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
-86,0 %
Net margin
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Drug Free Solution Inc provides healthcare services and equipment, primarily operating in the biotechnology segment of the healthcare industry.

Business. Drug Free Solution Inc (DSOL.PK) is a healthcare services and equipment company engaged in biotechnology activities. The firm operates within the healthcare facilities and services industry, generating revenue through service-based models. Headquarters location and specific operating segments are not disclosed in the available data. The company is listed on the OTC market under the ticker DSOL.PK.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-86,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning DSOL.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to DSOL.PK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Drug Free Solution Inc (DSOL.PK) is a healthcare services and equipment company engaged in biotechnology activities. The firm operates within the healthcare facilities and services industry, generating revenue through service-based models. Headquarters location and specific operating segments are not disclosed in the available data. The company is listed on the OTC market under the ticker DSOL.PK.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    Drug Free Solution Inc has a capital structure characterized by a total equity of $20,030,000 and no long-term debt, resulting in a debt-to-equity ratio of 0.0. The company's liquidity position is assessed as low, with an operating cash flow of -$625,330,000, indicating significant cash outflows from operations. This is further exacerbated by a negative return on equity of -0.8597, suggesting poor capital efficiency and profitability.

    Profitability metrics show that the company is currently unprofitable, with an operating income and net income of -$17,220,000. These figures are below the industry median for profitability metrics, indicating that the company is underperforming relative to its peers in the Healthcare Facilities & Services industry.

    The company's revenue concentration and geographic exposure are not explicitly detailed in the available data, but the absence of disclosed segments suggests a lack of diversification in its business operations. This could pose a risk if the company's primary market or product line experiences a downturn.

    The company's growth trajectory is uncertain, as there are no specific numeric deltas provided for the current or next fiscal year. However, the significant negative operating cash flow and net loss suggest that the company is not currently generating positive returns or experiencing growth. The absence of capital expenditures beyond -$4,870,000 also indicates limited investment in future growth.

    Risk factors for Drug Free Solution Inc include a low liquidity position and the potential for dilution, although the risk of dilution is currently assessed as low. The company has no immediate filing-based liquidity or dilution flags, but the negative operating cash flow and net loss could signal underlying financial stress. No adjustments have been applied to the valuation metrics, indicating that the reported figures are unadjusted.

    Recent events and filings do not show any significant developments that would impact the company's financial position or strategic direction. The absence of disclosed events or transcripts suggests a lack of recent material activity or communication from the company.

    Key takeaways
    • Drug Free Solution Inc is currently unprofitable with a net loss of $17,220,000 and a negative return on equity of -0.8597.
    • The company has no long-term debt and a debt-to-equity ratio of 0.0, indicating a conservative capital structure.
    • Operating cash flow is significantly negative at -$625,330,000, signaling liquidity challenges.
    • The company's growth trajectory is unclear, with no specific numeric deltas provided for the current or next fiscal year.
    • The risk of dilution is currently assessed as low, but the company's financial performance could change this outlook.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation FY

    Market price
    $0,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    0.0
    ROA
    ROE
    -86.0%
    Cash conversion
    3631.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    ROE-86,0 %Bottom quartile
    D/E0,00Above P75
    Cash Conv36,31Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Drug Free Solution Inc Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    DSOL.PKCanonical
    OTC · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage